Evaxion A/S Files May 2025 Report on Form 6-K
Ticker: EVAX · Form: 6-K · Filed: May 23, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: EVX
TL;DR
Evaxion A/S (EVX) filed its monthly 6-K, confirming 20-F annual report filings.
AI Summary
Evaxion A/S filed a Form 6-K on May 23, 2025, reporting its activities for the month of May 2025. The company, previously known as Evaxion Biotech A/S, is incorporated in G7 and has its principal executive offices in Hoersholm, Denmark. This filing is made under the Securities Exchange Act of 1934 and indicates that Evaxion A/S will file its annual reports under Form 20-F.
Why It Matters
This filing provides an update on Evaxion A/S's regulatory reporting status and confirms its adherence to SEC filing requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine filing confirming reporting status and does not contain new financial or operational information.
Key Players & Entities
- Evaxion A/S (company) — Registrant
- Evaxion Biotech A/S (company) — Former company name
- May 2025 (date) — Reporting period
- 20250523 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to report information that the company has made or is required to make public in its home country, has filed or is required to file with a stock exchange, or has distributed or is required to distribute to its security holders.
What is the reporting period for this Form 6-K?
The filing is for the month of May 2025.
Does Evaxion A/S file annual reports under Form 20-F or Form 40-F?
Evaxion A/S indicates it files annual reports under cover of Form 20-F.
What was Evaxion A/S's former company name?
Evaxion A/S was formerly known as Evaxion Biotech A/S, with a date of name change on October 14, 2020.
Where are Evaxion A/S's principal executive offices located?
The principal executive offices of Evaxion A/S are located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 23, 2025 regarding Evaxion A/S (EVAX).